Advertisement
Screener

SYNOVIS LIFE TECHNOLOGIES INC Quick Ratio

SYNOVIS LIFE TECHNOLOGIES INC Quick Ratio

  • Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2011-10-31..

Quick ratio

Overview →

Financial period ending 2011-10-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Quick ratio · latest quarter(m)Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2011-10-31.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash, securities and trade receivables(m)Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current
Current obligations10.02M USDLiabilities, Current
Cash and equivalents18.01M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables11.26M USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory · excluded from quick assets10.00M USDInventory, Net

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCash, securities and trade receivables (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory · excluded from quick assets (USD)Quick ratio
2011-10-31(m)$10.02M$18.01M(m)$11.26M$10.00M(m)
2011-07-31(m)$7.01M$18.21M(m)$10.48M$9.36M(m)
2010-10-31(m)$8.02M$12.95M(m)$8.70M$9.43M(m)
2010-07-31(m)(m)$9.94M(m)(m)(m)(m)
2009-10-31(m)(m)$15.86M(m)(m)(m)(m)
2008-10-31(m)(m)$46.90M(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.